These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

9189 related items for PubMed ID: 20175499

  • 21. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
    Furstoss C, Reniers B, Bertrand MJ, Poon E, Carrier JF, Keller BM, Pignol JP, Beaulieu L, Verhaegen F.
    Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
    [Abstract] [Full Text] [Related]

  • 22. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D, Pérez-Calatayud J, Ballester F, Casal E, de Frutos JM.
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [Abstract] [Full Text] [Related]

  • 23. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S, Vynckier S.
    Phys Med Biol; 2005 Apr 07; 50(7):1493-504. PubMed ID: 15798339
    [Abstract] [Full Text] [Related]

  • 24. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD, DeLuca PM, DeWerd LA.
    Med Phys; 2003 Apr 07; 30(4):701-11. PubMed ID: 12722822
    [Abstract] [Full Text] [Related]

  • 25. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F, Scalliet P, Vynckier S.
    Med Phys; 2008 Dec 07; 35(12):5841-50. PubMed ID: 19175140
    [Abstract] [Full Text] [Related]

  • 26. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M, Nilsson J, Lundell M, Carlsson Tedgren A.
    Brachytherapy; 2014 Dec 07; 13(6):651-6. PubMed ID: 24950821
    [Abstract] [Full Text] [Related]

  • 27. Monte Carlo-based dosimetry of proposed bi-radionuclide (125I and 106Ru/106Rh) eye plaque: A feasibility study.
    Mishra S, Selvam TP, Sahoo S, Saxena SK, Kumar Y, Sapra BK.
    Med Phys; 2024 Oct 07; 51(10):7561-7573. PubMed ID: 38935327
    [Abstract] [Full Text] [Related]

  • 28. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
    Asadi S, Vaez-Zadeh M, Vahidian M, Marghchouei M, Masoudi SF.
    J Appl Clin Med Phys; 2016 May 08; 17(3):90-99. PubMed ID: 27167265
    [Abstract] [Full Text] [Related]

  • 29. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
    McCauley Cutsinger S, Forsman R, Corner S, Deufel CL.
    Brachytherapy; 2019 May 08; 18(6):890-897. PubMed ID: 31444131
    [Abstract] [Full Text] [Related]

  • 30. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
    Johnson JE, Deufel CL, Furutani KM.
    Brachytherapy; 2016 May 08; 15(5):661-8. PubMed ID: 27475484
    [Abstract] [Full Text] [Related]

  • 31. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G, Reniers B, Murrer L, Lutgens L, Gurp EB, Pignol JP, Keller B, Beaulieu L, Verhaegen F.
    Med Phys; 2010 Oct 08; 37(10):5188-98. PubMed ID: 21089752
    [Abstract] [Full Text] [Related]

  • 32. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
    Aryal P, Molloy JA, Rivard MJ.
    Med Phys; 2014 Sep 08; 41(9):092102. PubMed ID: 25186402
    [Abstract] [Full Text] [Related]

  • 33. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
    Williamson JF, Butler W, Dewerd LA, Huq MS, Ibbott GS, Mitch MG, Nath R, Rivard MJ, Todor D, American Association of Physicists in Medicine.
    Med Phys; 2005 May 08; 32(5):1424-39. PubMed ID: 15984693
    [Abstract] [Full Text] [Related]

  • 34. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H, Menon G, Larocque MP, van Veelen B, Niatsetski Y, Weis E, Sloboda RS.
    Med Phys; 2018 Jul 08; 45(7):3349-3360. PubMed ID: 29729009
    [Abstract] [Full Text] [Related]

  • 35. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
    Lindsay P, Battista J, Van Dyk J.
    Med Phys; 2001 Mar 08; 28(3):336-45. PubMed ID: 11318315
    [Abstract] [Full Text] [Related]

  • 36. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
    Nuttens VE, Lucas S.
    Med Phys; 2006 Apr 08; 33(4):1101-7. PubMed ID: 16696487
    [Abstract] [Full Text] [Related]

  • 37. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
    Poder J, Corde S.
    Med Phys; 2013 Dec 08; 40(12):121709. PubMed ID: 24320495
    [Abstract] [Full Text] [Related]

  • 38. Comparison of 16 mm OSU-Nag and COMS eye plaques.
    Zhang H, Davidorf F, Qi Y.
    J Appl Clin Med Phys; 2012 May 10; 13(3):3632. PubMed ID: 22584165
    [Abstract] [Full Text] [Related]

  • 39. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT, Berson A, Szechter A.
    Ophthalmology; 1999 Mar 10; 106(3):606-13. PubMed ID: 10080222
    [Abstract] [Full Text] [Related]

  • 40. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
    Yue N, Chen Z, Nath R.
    Phys Med Biol; 2002 Apr 07; 47(7):1185-204. PubMed ID: 11996063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 460.